PharmacyCodes



Azlocilina [INN-Spanish] en es it fr

Azlocilina [INN-Spanish] Brand names, Azlocilina [INN-Spanish] Analogs

Azlocilina [INN-Spanish] Brand Names Mixture

  • No information avaliable

Azlocilina [INN-Spanish] Chemical_Formula

C20H23N5O6S

Azlocilina [INN-Spanish] RX_link

No information avaliable

Azlocilina [INN-Spanish] fda sheet

Azlocilina [INN-Spanish] msds (material safety sheet)

Azlocilina_[INN-Spanish] MSDS

Azlocilina [INN-Spanish] Synthesis Reference

No information avaliable

Azlocilina [INN-Spanish] Molecular Weight

461.493 g/mol

Azlocilina [INN-Spanish] Melting Point

No information avaliable

Azlocilina [INN-Spanish] H2O Solubility

Sodium salt is soluble in water (50 mg/ml)

Azlocilina [INN-Spanish] State

Solid

Azlocilina [INN-Spanish] LogP

-0.046

Azlocilina [INN-Spanish] Dosage Forms

Solution (for intramuscular injection or intravenous infusion)

Azlocilina [INN-Spanish] Indication

For the treatment of infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae.

Azlocilina [INN-Spanish] Pharmacology

Azlocillin, similar to mezlocillin and piperacillin, is an acylampicillin with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin demonstrates antibacterial activity against a broad spectrum of bacteria, including Pseudomonas aeruginosa, and, in contrast to most cephalosporins, exhibits activity against enterococci.

Azlocilina [INN-Spanish] Absorption

Not significantly absorbed from the gastrointestinal tract.

Azlocilina [INN-Spanish] side effects and Toxicity

No information avaliable

Azlocilina [INN-Spanish] Patient Information

Azlocilina [INN-Spanish] Organisms Affected

Enteric bacteria and other eubacteria